P53 and breast cancer, an update

被引:300
作者
Lacroix, Marc [1 ]
Toillon, Robert-Alain [1 ]
Leclercq, Guy [1 ]
机构
[1] Free Univ Brussels, Inst Jules Bordet, Lab Jean Claude Heuson Cancerol Mammaire, B-1000 Brussels, Belgium
关键词
D O I
10.1677/erc.1.01172
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
p53 plays a key role in mediating cell response to various stresses, mainly by inducing or repressing a number of genes involved in cell cycle arrest, senescence, apoptosis, DNA repair, and angiogenesis. According to this important function, p53 activity is controlled in a very complex manner, including several auto-regulatory loops, through the intervention of dozens of modulator proteins (the 'p53 interactome'). p53 mutations are observed in a significant minority of breast tumours. In the remaining cases, alterations of interactome components or target genes could contribute, to some extent, to reduce the ability of p53 to efficiently manage stress events. While the prognostic and predictive value of p53 is still debated, there is an increasing interest for p53-based therapies. The present paper aims to provide updated information on p53 regulation and function, with specific interest on its role in breast cancer.
引用
收藏
页码:293 / 325
页数:33
相关论文
共 209 条
[91]   Molecular interaction map of the p53 and Mdm2 logic elements, which control the Off-On switch of p53 in response to DNA damage [J].
Kohn, KW ;
Pommier, Y .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 331 (03) :816-827
[92]   The "portait" of hereditary breast cancer [J].
Lacroix, M ;
Leclercq, G .
BREAST CANCER RESEARCH AND TREATMENT, 2005, 89 (03) :297-304
[93]   About GATA3, HNF3A, and XBP1, three genes co-expressed with the oestrogen receptor-α gene (ESRI) in breast cancer [J].
Lacroix, M ;
Leclercq, G .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2004, 219 (1-2) :1-7
[94]   Stable 'portrait' of breast tumors during progression: data from biology, pathology and genetics [J].
Lacroix, M ;
Toillon, RA ;
Leclercq, G .
ENDOCRINE-RELATED CANCER, 2004, 11 (03) :497-522
[95]   Relevance of breast cancer cell lines as models for breast tumours: an update [J].
Lacroix, M ;
Leclercq, G .
BREAST CANCER RESEARCH AND TREATMENT, 2004, 83 (03) :249-289
[96]   Spectrum of p53 tumor suppressor gene mutations and breast cancer survival [J].
Lai, H ;
Ma, FC ;
Trapido, E ;
Meng, L ;
Lai, SH .
BREAST CANCER RESEARCH AND TREATMENT, 2004, 83 (01) :57-66
[97]   Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation [J].
Leng, RP ;
Lin, YP ;
Ma, WL ;
Wu, H ;
Lemmers, B ;
Chung, S ;
Parant, JM ;
Lozano, G ;
Hakem, R ;
Benchimol, S .
CELL, 2003, 112 (06) :779-791
[98]   C-Abl as a modulator of p53 [J].
Levav-Cohen, Y ;
Goldberg, Z ;
Zuckerman, V ;
Grossman, T ;
Haupt, S ;
Haupt, Y .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 331 (03) :737-749
[99]   The codon 47 polymorphism in p53 is functionally significant [J].
Li, XX ;
Dumont, P ;
Della Pietra, A ;
Shetler, C ;
Murphy, ME .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (25) :24245-24251
[100]  
Li Z., 2004, Journal of Musculoskeletal & Neuronal Interactions, V4, P64